These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192 [TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742 [TBL] [Abstract][Full Text] [Related]
13. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938 [TBL] [Abstract][Full Text] [Related]
14. Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia. Schweitzer-Krantz S Eur J Pediatr; 2003 Dec; 162 Suppl 1():S50-3. PubMed ID: 14614623 [TBL] [Abstract][Full Text] [Related]
15. Galactosaemia: case for neonatal screening illustrated by recent Australian experience. Masters P; Langton S; Robertson E; Hill G Med J Aust; 1978 Oct; 2(8):348-52. PubMed ID: 732709 [TBL] [Abstract][Full Text] [Related]
16. Galactosaemia - should it be screened in newborns? Bosch AM Dev Period Med; 2018; 22(3):221-224. PubMed ID: 30281516 [No Abstract] [Full Text] [Related]